Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander L Gerbes

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Digestion|January 5, 2023
Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune HepatitisSabine Weber, Alexander L Gerbes
Deutsches Arzteblatt International|February 9, 2021
Liver InvolvementAlexander L Gerbes, Sabine Weber
Hepatobiliary Surgery and Nutrition|October 27, 2023
Update on herbal and dietary supplement-induced liver injury: current gaps and future directionsSabine Weber, Alexander L Gerbes
World Journal of Gastroenterology|February 21, 2006
Progress in treatment of massive ascites and hepatorenal syndromeAlexander L Gerbes, Veit Gulberg
International Journal of Molecular Sciences|June 10, 2022
Challenges and Future of Drug-Induced Liver Injury Research-Laboratory TestsSabine Weber, Alexander L Gerbes
Gut|July 27, 2022
COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admissionSabine Weber, Alexander L Gerbes
Hepatology (Baltimore, Md.)|December 25, 2004
Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the differenceAlexander L Gerbes, Veit Gülberg
Digestive Diseases (Basel, Switzerland)|July 11, 2015
The Challenge of Drug-Induced Liver Injury (DILI) / Challenges and Management of Liver Cirrhosis. PrefaceAlexander L Gerbes, Hartmut Jaeschke
Digestive Diseases (Basel, Switzerland)|July 11, 2015
Drug-Induced Liver Injury and Individual Cell ModelsAndreas Benesic, Alexander L Gerbes
Hepatology (Baltimore, Md.)|October 1, 2009
Role of cholesterol determination in ascitic fluid analysisAlexander L Gerbes, Dieter Jüngst
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Digestion|January 5, 2023
Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune HepatitisSabine Weber, Alexander L Gerbes
Deutsches Arzteblatt International|February 9, 2021
Liver InvolvementAlexander L Gerbes, Sabine Weber
Hepatobiliary Surgery and Nutrition|October 27, 2023
Update on herbal and dietary supplement-induced liver injury: current gaps and future directionsSabine Weber, Alexander L Gerbes
World Journal of Gastroenterology|February 21, 2006
Progress in treatment of massive ascites and hepatorenal syndromeAlexander L Gerbes, Veit Gulberg
International Journal of Molecular Sciences|June 10, 2022
Challenges and Future of Drug-Induced Liver Injury Research-Laboratory TestsSabine Weber, Alexander L Gerbes
Gut|July 27, 2022
COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admissionSabine Weber, Alexander L Gerbes
Hepatology (Baltimore, Md.)|December 25, 2004
Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the differenceAlexander L Gerbes, Veit Gülberg
Digestive Diseases (Basel, Switzerland)|July 11, 2015
The Challenge of Drug-Induced Liver Injury (DILI) / Challenges and Management of Liver Cirrhosis. PrefaceAlexander L Gerbes, Hartmut Jaeschke
Digestive Diseases (Basel, Switzerland)|July 11, 2015
Drug-Induced Liver Injury and Individual Cell ModelsAndreas Benesic, Alexander L Gerbes
Hepatology (Baltimore, Md.)|October 1, 2009
Role of cholesterol determination in ascitic fluid analysisAlexander L Gerbes, Dieter Jüngst
Pageof 14